Please enable JavaScript to continue using this application.

Compare $CTOR vs $SERA | Chartloom

Compare

$CTOR vs $SERA

Citius Oncology Inc · Sera Prognostics Inc

CTOR

Citius Oncology Inc

SERA

Sera Prognostics Inc

Compare $CTOR vs $SERA

Comparing Citius Oncology Inc and Sera Prognostics Inc

CTORCitius Oncology Inc

SERASera Prognostics Inc

CTORCitius Oncology Inc

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.10x

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-54.4%

FCF yield

-24.8%

SERASera Prognostics Inc

Market cap

$80M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

89.94x

Rev growth (TTM)

-35.2%

YTD performance

-32.0%

52W performance

-35.2%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTOR

SERA

Detailed metrics comparison

CTOR

Citius Oncology Inc

SERA

Sera Prognostics Inc

Market Cap

CTOR$78M

SERA$80M

Enterprise Value

CTOR$72M

SERA$75M

Price

CTOR$0.84

SERA$2.04

P/E Ratio

CTORN/A

SERAN/A

P/S Ratio

CTOR10.99x

SERA1,141.23x

EV/Sales

CTOR10.10x

SERA1,078.41x

EV/EBITDA

CTOR0.00x

SERA0.00x

P/B Ratio

CTOR2.19x

SERA1.39x

P/FCF Ratio

CTORN/A

SERAN/A

EV/FCF

CTOR-3.70x

SERA-2.68x

PEG Ratio

CTORN/A

SERAN/A

Forward P/E (NTM)

CTORN/A

SERAN/A

Forward P/S (NTM)

CTOR1.10x

SERA89.94x

Revenue (TTM)

CTOR$7M

SERA$70K

Revenue Growth (YoY)

CTORN/A

SERA-35.2%

Forward Rev Growth

CTOR65.4%

SERA791.9%

Gross Margin (TTM)

CTOR77.3%

SERA-150.0%

Operating Margin (TTM)

CTOR0.0%

SERA0.0%

EBITDA Margin (TTM)

CTOR-542.8%

SERA-50200.0%

Net Margin (TTM)

CTOR-648.3%

SERA-47475.7%

FCF Margin (TTM)

CTOR-272.9%

SERA-40262.9%

Net Income (TTM)

CTOR$-46M

SERA$-33M

FCF (TTM)

CTOR$-19M

SERA$-28M

EPS (TTM)

CTOR-$0.43

SERA-$0.66

ROE (TTM)

CTOR-10298.0%

SERA-4671.0%

ROA (TTM)

CTOR-4349.0%

SERA-3406.0%

ROIC (TTM)

CTOR-9188.0%

SERA-4671.0%

Cash

CTOR$17M

SERA$4M

Debt

CTOR$10M

SERA$0

Net Cash/Debt

CTOR$6M

SERA$4M

Current Ratio (TTM)

CTOR0.73x

SERA1.98x

Quick Ratio (TTM)

CTOR0.29x

SERA1.91x

Debt/Equity (TTM)

CTOR0.25x

SERA0.00x

Debt/Assets (TTM)

CTOR0.0%

SERA0.0%

Interest Coverage (TTM)

CTORN/A

SERAN/A

Net Debt/EBITDA (TTM)

CTOR0.00x

SERA0.00x

Beta

CTOR3.34

SERA1.09

52W Performance

CTOR-54.4%

SERA-35.2%

YTD Performance

CTOR-22.2%

SERA-32.0%

% from 52W High

CTOR-62.7%

SERA-48.4%

% from 52W Low

CTOR71.0%

SERA30.8%

Asset Turnover (TTM)

CTOR0.00x

SERA0.00x

FCF Yield (TTM)

CTOR-24.8%

SERA-35.3%

Earnings Yield (TTM)

CTOR-59.0%

SERA-41.6%

Dividend Yield (TTM)

CTORN/A

SERAN/A

Rule of 40

CTOR-272.9

SERA-40,298.0

EV/GP/RG

CTOR0.01

SERAN/A

Ticker research

View CTOR research View SERA research

Metric	CTOR Citius Oncology Inc	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$78M	$80M
Enterprise Value	$72M	$75M
Price	$0.84	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	10.99x	1,141.23x
EV/Sales	10.10x	1,078.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.19x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.70x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.10x	89.94x
Revenue & Growth
Revenue (TTM)	$7M	$70K
Revenue Growth (YoY)	N/A	-35.2%
Forward Rev Growth	65.4%	791.9%
Profitability
Gross Margin (TTM)	77.3%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-542.8%	-50200.0%
Net Margin (TTM)	-648.3%	-47475.7%
FCF Margin (TTM)	-272.9%	-40262.9%
Net Income (TTM)	$-46M	$-33M
FCF (TTM)	$-19M	$-28M
EPS (TTM)	-$0.43	-$0.66
ROE (TTM)	-10298.0%	-4671.0%
ROA (TTM)	-4349.0%	-3406.0%
ROIC (TTM)	-9188.0%	-4671.0%
Financial Health
Cash	$17M	$4M
Debt	$10M	$0
Net Cash/Debt	$6M	$4M
Current Ratio (TTM)	0.73x	1.98x
Quick Ratio (TTM)	0.29x	1.91x
Debt/Equity (TTM)	0.25x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.34	1.09
52W Performance	-54.4%	-35.2%
YTD Performance	-22.2%	-32.0%
% from 52W High	-62.7%	-48.4%
% from 52W Low	71.0%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.8%	-35.3%
Earnings Yield (TTM)	-59.0%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.9	-40,298.0
EV/GP/RG	0.01	N/A
Ticker research	View CTOR research	View SERA research

Valuation

P/S Ratio

CTOR

10.99x

SERA

1,141.23x

EV/FCF

CTOR

-3.70x

SERA

-2.68x

Growth & revenue

Revenue Growth TTM

SERA

-35.2%

Forward Revenue Growth

SERA

791.9%

CTOR

65.4%

Profitability & performance

Gross Margin

CTOR

77.3%

SERA

-150.0%

ROE

SERA

-4671.0%

CTOR

-10298.0%

FCF Yield %

CTOR

-24.8%

SERA

-35.3%

52-Week Performance

SERA

-35.2%

CTOR

-54.4%

Detailed metrics comparison

CTOR

Citius Oncology Inc

SERA

Sera Prognostics Inc

Market Cap

CTOR$78M

SERA$80M

Enterprise Value

CTOR$72M

SERA$75M

Price

CTOR$0.84

SERA$2.04

P/E Ratio

CTORN/A

SERAN/A

P/S Ratio

CTOR10.99x

SERA1,141.23x

EV/Sales

CTOR10.10x

SERA1,078.41x

EV/EBITDA

CTOR0.00x

SERA0.00x

P/B Ratio

CTOR2.19x

SERA1.39x

P/FCF Ratio

CTORN/A

SERAN/A

EV/FCF

CTOR-3.70x

SERA-2.68x

PEG Ratio

CTORN/A

SERAN/A

Forward P/E (NTM)

CTORN/A

SERAN/A

Forward P/S (NTM)

CTOR1.10x

SERA89.94x

Revenue (TTM)

CTOR$7M

SERA$70K

Revenue Growth (YoY)

CTORN/A

SERA-35.2%

Forward Rev Growth

CTOR65.4%

SERA791.9%

Gross Margin (TTM)

CTOR77.3%

SERA-150.0%

Operating Margin (TTM)

CTOR0.0%

SERA0.0%

EBITDA Margin (TTM)

CTOR-542.8%

SERA-50200.0%

Net Margin (TTM)

CTOR-648.3%

SERA-47475.7%

FCF Margin (TTM)

CTOR-272.9%

SERA-40262.9%

Net Income (TTM)

CTOR$-46M

SERA$-33M

FCF (TTM)

CTOR$-19M

SERA$-28M

EPS (TTM)

CTOR-$0.43

SERA-$0.66

ROE (TTM)

CTOR-10298.0%

SERA-4671.0%

ROA (TTM)

CTOR-4349.0%

SERA-3406.0%

ROIC (TTM)

CTOR-9188.0%

SERA-4671.0%

Cash

CTOR$17M

SERA$4M

Debt

CTOR$10M

SERA$0

Net Cash/Debt

CTOR$6M

SERA$4M

Current Ratio (TTM)

CTOR0.73x

SERA1.98x

Quick Ratio (TTM)

CTOR0.29x

SERA1.91x

Debt/Equity (TTM)

CTOR0.25x

SERA0.00x

Debt/Assets (TTM)

CTOR0.0%

SERA0.0%

Interest Coverage (TTM)

CTORN/A

SERAN/A

Net Debt/EBITDA (TTM)

CTOR0.00x

SERA0.00x

Beta

CTOR3.34

SERA1.09

52W Performance

CTOR-54.4%

SERA-35.2%

YTD Performance

CTOR-22.2%

SERA-32.0%

% from 52W High

CTOR-62.7%

SERA-48.4%

% from 52W Low

CTOR71.0%

SERA30.8%

Asset Turnover (TTM)

CTOR0.00x

SERA0.00x

FCF Yield (TTM)

CTOR-24.8%

SERA-35.3%

Earnings Yield (TTM)

CTOR-59.0%

SERA-41.6%

Dividend Yield (TTM)

CTORN/A

SERAN/A

Rule of 40

CTOR-272.9

SERA-40,298.0

EV/GP/RG

CTOR0.01

SERAN/A

Ticker research

View CTOR research View SERA research

Metric	CTOR Citius Oncology Inc	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$78M	$80M
Enterprise Value	$72M	$75M
Price	$0.84	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	10.99x	1,141.23x
EV/Sales	10.10x	1,078.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.19x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.70x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.10x	89.94x
Revenue & Growth
Revenue (TTM)	$7M	$70K
Revenue Growth (YoY)	N/A	-35.2%
Forward Rev Growth	65.4%	791.9%
Profitability
Gross Margin (TTM)	77.3%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-542.8%	-50200.0%
Net Margin (TTM)	-648.3%	-47475.7%
FCF Margin (TTM)	-272.9%	-40262.9%
Net Income (TTM)	$-46M	$-33M
FCF (TTM)	$-19M	$-28M
EPS (TTM)	-$0.43	-$0.66
ROE (TTM)	-10298.0%	-4671.0%
ROA (TTM)	-4349.0%	-3406.0%
ROIC (TTM)	-9188.0%	-4671.0%
Financial Health
Cash	$17M	$4M
Debt	$10M	$0
Net Cash/Debt	$6M	$4M
Current Ratio (TTM)	0.73x	1.98x
Quick Ratio (TTM)	0.29x	1.91x
Debt/Equity (TTM)	0.25x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.34	1.09
52W Performance	-54.4%	-35.2%
YTD Performance	-22.2%	-32.0%
% from 52W High	-62.7%	-48.4%
% from 52W Low	71.0%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.8%	-35.3%
Earnings Yield (TTM)	-59.0%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.9	-40,298.0
EV/GP/RG	0.01	N/A
Ticker research	View CTOR research	View SERA research